Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam López-Ramos

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Chemical Information and Modeling|April 3, 2010
HPPD: ligand- and target-based virtual screening on a herbicide targetMiriam López-Ramos, Francesca Perruccio
Future Medicinal Chemistry|February 17, 2015
Progress toward JAK1-selective inhibitorsChristel J Menet, Oscar Mammoliti, Miriam López-Ramos
Biochimica Et Biophysica Acta|August 5, 2008
Salicylaldehyde derivatives as new protein kinase CK2 inhibitorsRenaud Prudent, Miriam López-Ramos, Virginie Moucadel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 20, 2010
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insightsMiriam López-Ramos, Renaud Prudent, Virginie Moucadel, et al.
Molecular and Cellular Biochemistry|June 20, 2008
Expanding the chemical diversity of CK2 inhibitorsRenaud Prudent, Virginie Moucadel, Miriam López-Ramos, et al.
Journal of Medicinal Chemistry|May 28, 2024
Discovery of GLPG3667, a Selective ATP Competitive Tyrosine Kinase 2 Inhibitor for the Treatment of Autoimmune DiseasesOscar Mammoliti, Sébastien Martina, Pieter Claes, et al.
Bioorganic & Medicinal Chemistry|October 24, 2024
Design of a potent and selective dual JAK1/TYK2 inhibitorOscar Mammoliti, Christel Menet, Céline Cottereaux, et al.
Journal of Medicinal Chemistry|December 26, 2023
Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312Taouès Temal-Laib, Christophe Peixoto, Nicolas Desroy, et al.
Journal of Medicinal Chemistry|March 29, 2024
Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory DiseasesChristophe Peixoto, Agnes Joncour, Taouès Temal-Laib, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2025
Discovery of GLPG4471, a potent and selective IRAK4 inhibitor for the treatment of inflammatory and autoimmune diseasesOscar Mammoliti, Florence Bonnaterre, Gregory Newsome, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Chemical Information and Modeling|April 3, 2010
HPPD: ligand- and target-based virtual screening on a herbicide targetMiriam López-Ramos, Francesca Perruccio
Future Medicinal Chemistry|February 17, 2015
Progress toward JAK1-selective inhibitorsChristel J Menet, Oscar Mammoliti, Miriam López-Ramos
Biochimica Et Biophysica Acta|August 5, 2008
Salicylaldehyde derivatives as new protein kinase CK2 inhibitorsRenaud Prudent, Miriam López-Ramos, Virginie Moucadel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 20, 2010
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insightsMiriam López-Ramos, Renaud Prudent, Virginie Moucadel, et al.
Molecular and Cellular Biochemistry|June 20, 2008
Expanding the chemical diversity of CK2 inhibitorsRenaud Prudent, Virginie Moucadel, Miriam López-Ramos, et al.
Journal of Medicinal Chemistry|May 28, 2024
Discovery of GLPG3667, a Selective ATP Competitive Tyrosine Kinase 2 Inhibitor for the Treatment of Autoimmune DiseasesOscar Mammoliti, Sébastien Martina, Pieter Claes, et al.
Bioorganic & Medicinal Chemistry|October 24, 2024
Design of a potent and selective dual JAK1/TYK2 inhibitorOscar Mammoliti, Christel Menet, Céline Cottereaux, et al.
Journal of Medicinal Chemistry|December 26, 2023
Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312Taouès Temal-Laib, Christophe Peixoto, Nicolas Desroy, et al.
Journal of Medicinal Chemistry|March 29, 2024
Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory DiseasesChristophe Peixoto, Agnes Joncour, Taouès Temal-Laib, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2025
Discovery of GLPG4471, a potent and selective IRAK4 inhibitor for the treatment of inflammatory and autoimmune diseasesOscar Mammoliti, Florence Bonnaterre, Gregory Newsome, et al.
Pageof 1